Ionis Pharmaceuticals (NASDAQ: IONS)
Ionis Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ionis Pharmaceuticals Company Info
Ionis Pharmaceuticals is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
News & Analysis
Ionis Pharmaceuticals Beats on Revenue
Ionis Pharmaceuticals posted better-than-expected revenue in the third quarter, but faced challenges as it prepares to bring new treatments to market.
2 Growth Stocks That Are Unapologetically Crushing the Bear Market
There's more than one factor driving recent outperformance of these shares.
Why Ionis Pharmaceuticals Stock Is Down 13% This Week
An experimental treatment for amyotrophic lateral sclerosis missed the mark in a phase 3 trial.
The Best Biotech Stocks to Buy With $500
A modest amount goes a long way when you invest in biotech stocks.
Here's Why Ionis Pharmaceuticals Stock Got Slammed Today
The biotech's partner is stopping a late-stage clinical trial for a Huntington's disease treatment.
What's Behind Ionis Pharmaceuticals' Q3 Earnings Disappointment
The main problem: a lackluster performance for Spinraza.
Is Ionis Pharmaceuticals a Buy?
Here's what it takes to justify the current valuation.
Got $3,000? Here Are 3 Great Biotech Stocks to Buy Right Now
One big biotech and two small biotechs especially stand out as attractive picks.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.